Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Deciphering the Role of B Cells in Multiple Sclerosis-Towards Specific Targeting of Pathogenic Function.

Lehmann-Horn K, Kinzel S, Weber MS.

Int J Mol Sci. 2017 Sep 23;18(10). pii: E2048. doi: 10.3390/ijms18102048. Review.

2.

Frequencies of neuronal autoantibodies in healthy controls: Estimation of disease specificity.

Lang K, Prüss H.

Neurol Neuroimmunol Neuroinflamm. 2017 Jul 18;4(5):e386. doi: 10.1212/NXI.0000000000000386. eCollection 2017 Sep. Review.

3.

The Role of Peripheral CNS-Directed Antibodies in Promoting Inflammatory CNS Demyelination.

Kinzel S, Weber MS.

Brain Sci. 2017 Jun 22;7(7). pii: E70. doi: 10.3390/brainsci7070070. Review.

4.

Expanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System.

Pilli D, Zou A, Tea F, Dale RC, Brilot F.

Front Immunol. 2017 Jun 7;8:652. doi: 10.3389/fimmu.2017.00652. eCollection 2017. Review.

5.

Engineered clearing agents for the selective depletion of antigen-specific antibodies.

Devanaboyina SC, Khare P, Challa DK, Ober RJ, Ward ES.

Nat Commun. 2017 May 31;8:15314. doi: 10.1038/ncomms15314.

6.

Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.

Peschl P, Bradl M, Höftberger R, Berger T, Reindl M.

Front Immunol. 2017 May 8;8:529. doi: 10.3389/fimmu.2017.00529. eCollection 2017. Review.

7.

Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system.

Sinmaz N, Nguyen T, Tea F, Dale RC, Brilot F.

J Neuroinflammation. 2016 Aug 30;13(1):219. doi: 10.1186/s12974-016-0678-4. Review.

8.

Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis.

Spadaro M, Gerdes LA, Krumbholz M, Ertl-Wagner B, Thaler FS, Schuh E, Metz I, Blaschek A, Dick A, Brück W, Hohlfeld R, Meinl E, Kümpfel T.

Neurol Neuroimmunol Neuroinflamm. 2016 Jun 30;3(5):e257. doi: 10.1212/NXI.0000000000000257. eCollection 2016 Oct.

9.

Regulatory T Cell Dysfunction Acquiesces to BTLA+ Regulatory B Cells Subsequent to Oral Intervention in Experimental Autoimmune Encephalomyelitis.

Huarte E, Jun S, Rynda-Apple A, Golden S, Jackiw L, Hoffman C, Maddaloni M, Pascual DW.

J Immunol. 2016 Jun 15;196(12):5036-46. doi: 10.4049/jimmunol.1501973. Epub 2016 May 18.

10.

Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen.

Kinzel S, Lehmann-Horn K, Torke S, Häusler D, Winkler A, Stadelmann C, Payne N, Feldmann L, Saiz A, Reindl M, Lalive PH, Bernard CC, Brück W, Weber MS.

Acta Neuropathol. 2016 Jul;132(1):43-58. doi: 10.1007/s00401-016-1559-8. Epub 2016 Mar 29.

11.

B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions.

Claes N, Fraussen J, Stinissen P, Hupperts R, Somers V.

Front Immunol. 2015 Dec 21;6:642. doi: 10.3389/fimmu.2015.00642. eCollection 2015. Review.

12.

Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases.

Riedhammer C, Weissert R.

Front Immunol. 2015 Jun 17;6:322. doi: 10.3389/fimmu.2015.00322. eCollection 2015. Review.

13.

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease.

Waters P, Woodhall M, O'Connor KC, Reindl M, Lang B, Sato DK, Juryńczyk M, Tackley G, Rocha J, Takahashi T, Misu T, Nakashima I, Palace J, Fujihara K, Leite MI, Vincent A.

Neurol Neuroimmunol Neuroinflamm. 2015 Mar 19;2(3):e89. doi: 10.1212/NXI.0000000000000089. eCollection 2015 Jun.

14.

Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis.

Ramanathan S, Reddel SW, Henderson A, Parratt JD, Barnett M, Gatt PN, Merheb V, Kumaran RY, Pathmanandavel K, Sinmaz N, Ghadiri M, Yiannikas C, Vucic S, Stewart G, Bleasel AF, Booth D, Fung VS, Dale RC, Brilot F.

Neurol Neuroimmunol Neuroinflamm. 2014 Oct 29;1(4):e40. doi: 10.1212/NXI.0000000000000040. eCollection 2014 Dec.

15.

Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton.

Dale RC, Tantsis EM, Merheb V, Kumaran RY, Sinmaz N, Pathmanandavel K, Ramanathan S, Booth DR, Wienholt LA, Prelog K, Clark DR, Guillemin GJ, Lim CK, Mathey EK, Brilot F.

Neurol Neuroimmunol Neuroinflamm. 2014 May 22;1(1):e12. doi: 10.1212/NXI.0000000000000012. eCollection 2014 Jun.

16.

Disease risk factors identified through shared genetic architecture and electronic medical records.

Li L, Ruau DJ, Patel CJ, Weber SC, Chen R, Tatonetti NP, Dudley JT, Butte AJ.

Sci Transl Med. 2014 Apr 30;6(234):234ra57. doi: 10.1126/scitranslmed.3007191.

17.

Autoantibodies to Non-myelin Antigens as Contributors to the Pathogenesis of Multiple Sclerosis.

Levin MC, Lee S, Gardner LA, Shin Y, Douglas JN, Cooper C.

J Clin Cell Immunol. 2013 Jun 30;4. doi: 10.4172/2155-9899.1000148.

18.

Novel pathogenic epitopes of myelin oligodendrocyte glycoprotein induce experimental autoimmune encephalomyelitis in C57BL/6 mice.

Delarasse C, Smith P, Baker D, Amor S.

Immunology. 2013 Dec;140(4):456-64. doi: 10.1111/imm.12155.

19.

Induction of experimental autoimmune encephalomyelitis with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund's adjuvant in three non-human primate species.

Haanstra KG, Jagessar SA, Bauchet AL, Doussau M, Fovet CM, Heijmans N, Hofman SO, van Lubeek-Veth J, Bajramovic JJ, Kap YS, Laman JD, Touin H, Watroba L, Bauer J, Lachapelle F, Serguera C, 't Hart BA.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1251-64. doi: 10.1007/s11481-013-9487-z. Epub 2013 Jul 3.

20.

IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis.

Benkhoucha M, Molnarfi N, Santiago-Raber ML, Weber MS, Merkler D, Collin M, Lalive PH.

J Neuroinflammation. 2012 Sep 3;9:209.

Supplemental Content

Support Center